The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
By Jean-Pierre Lindenmayer, David Brown, Sherry Liu,
-
ORIGINAL RESEARCHCriteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
By Prakash S. Masand, MD, James Eudicone, MS, Andrei Pikalov, MD, PhD, Robert D. McQuade, PhD, Ronald N. Marcus, MD, Estelle Vester-Blokland, MD and Berit X. Carlson, PhD
-
ORIGINAL RESEARCHClinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
By Mark A. Demitrack, Michael E. Thase
-
GENERAL PSYCHIATRYOff-Label Second Generation Antipsychotics for Impulse Regulation Disorders: A Review
Albertine Scheltema Beduin, Lieuwe de Haan
-
Signal Detection and Placebo Response in Schizophrenia: Parallels with Depression
By Craig H. Mallinckrodt, Lu Zhang, William R. Prucka, Brian A. Millen
-
All GradWorks Special Projects are Subject to Medical Updates & are Available for Sponsorship via Unrestricted Educational Grant.
